Pay in 4 interest-free payments of $7.11 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
6.1 Modulating the gut microbiota Modulating the gut microbiota has emerged as a possible treatment option in PD, where dysbiosis-induced inflammation, reduced SCFA synthesis, and altered neurotrophic signaling all contribute to neurodegeneration
De novo phosphatidylethanolamine synthesis via the cytidine diphosphate-ethanolamine pathway is critical for maintaining CXCR5 surface expression by preventing its internalization and degradation
The 4-phase repair model: Anti-inflammatory phase (KPV): KPV reduces excessive inflammation that hinders the healing process
Y., Milsom, J
US$ 24.51
US$ 22.55
US$ 24.01
US$ 22.02
